Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications-Reference-Cited by-同舟云学术

Ceftolozane/tazobactam for difficult-to-treat Pseudomonas aeruginosa infections: A systematic review of its efficacy and safety for off-label indications

Published:2020-03 Issue:3 Volume:55 Page:105891
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Maraolo Alberto Enrico,Mazzitelli Maria,Trecarichi Enrico Maria,Buonomo Antonio Riccardo,Torti Carlo,Gentile Ivan

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference80 articles.

1. What is the role of the new β-lactam/β-lactamase inhibitors ceftolozane/tazobactam and ceftazidime/avibactam?;Gentile;Expert Rev Anti Infect Ther,2016

2. Ceftolozane/tazobactam plus metronidazole for complicated intraabdominal infections in an era of multidrug resistance: results from a randomized, double-blind, phase 3 trial (ASPECT-cIAI);Solomkin;Clin Infect Dis,2015

3. Ceftolozane–tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI);Wagenlehner;Lancet,2015

4. The ‘old’ and the ‘new’ antibiotics for MDR Gram-negative pathogens: for whom, when, and how;Karaiskos;Front Public Health,2019

5. Healthcare-associated pneumonia in acute care hospitals in European Union/European Economic Area countries: an analysis of data from a point prevalence survey, 2011 to 2012;Walter;Euro Surveill,2018

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of Pseudomonas aeruginosa quorum sensing by methyl gallate from Mangifera indica;Scientific Reports;2023-10-20

2. Management strategies for severe Pseudomonas aeruginosa infections;Current Opinion in Infectious Diseases;2023-10-12

3. Antimicrobial susceptibility of ceftolozane-tazobactam against multidrug-resistant Pseudomonas aeruginosa isolates from Melbourne, Australia;Pathology;2023-08

4. Pseudomonas—Spectrum of Disease Presentations for the Inpatient Dermatologist;Current Dermatology Reports;2023-06-09

5. Comparative in vitro antipseudomonal activity of ceftolozane/tazobactam against Pseudomonas aeruginosa isolates from children with cystic fibrosis;Diagnostic Microbiology and Infectious Disease;2023-04